A New Detailed Term Accounting Opacity Code: TOPAZ

por Iglesias, C A, Chen, M H, Isaacs, W A, Sonnad, V, Wilson, B G
Publicado 2004

Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci

por Brown, W M, Lange, E M, Chen, H, Zheng, S L, Chang, B, Wiley, K E, Isaacs, S D, Walsh, P C, Isaacs, W B, Xu, J, Cooney, K A
Publicado 2004

Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer

por Chang, B L, Zheng, S L, Isaacs, S D, Turner, A, Hawkins, G A, Wiley, K E, Bleecker, E R, Walsh, P C, Meyers, D A, Isaacs, W B, Xu, J
Publicado 2003

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk

por Lindmark, F, Zheng, S L, Wiklund, F, Bälter, K A, Sun, J, Chang, B, Hedelin, M, Clark, J, Johansson, J-E, Meyers, D A, Adami, H-O, Isaacs, W, Grönberg, H, Xu, J
Publicado 2005

Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration

por Sutcliffe, S, Nevin, R L, Pakpahan, R, Elliott, D J, Cole, S R, De Marzo, A M, Gaydos, C A, Isaacs, W B, Nelson, W G, Sokoll, L J, Zenilman, J M, Cersovsky, S B, Platz, E A
Publicado 2011

Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy

por Woodcock, D. J., Riabchenko, E., Taavitsainen, S., Kankainen, M., Gundem, G., Brewer, D. S., Ellonen, P., Lepistö, M., Golubeva, Y. A., Warner, A. C., Tolonen, T., Jasu, J., Isaacs, W. B., Emmert-Buck, M. R., Nykter, M., Visakorpi, T., Bova, G. S., Wedge, D. C.
Publicado 2020